Redhill Biopharma

RedHill Biopharma shares jump as Ebola treatment shows promise
Marketwatch
Thu, 12/21/23 - 09:56 am
Redhill Biopharma
ebola virus
opaganib
RHB-107
RedHill's 2nd try COVID pill staves off hospitalization in phase 2
Fierce Biotech
Tue, 03/1/22 - 10:15 pm
Redhill Biopharma
COVID-19
clinical trials
RedHill’s oral drug boosts Veklury efficacy in severe COVID
Pharmaforum
Tue, 02/8/22 - 09:54 am
Redhill Biopharma
COVID-19
Veklury
Gilead Sciences
RedHill Biopharma Ltd Announces RedHill's Opaganib Strong Delta Variant Inhibition
Yahoo Finance
Fri, 08/27/21 - 10:41 am
Redhill Biopharma
opaganib
COVID-19
clinical trials
Delta COVID-19 variant
RedHill posts data in COVID-19 patients on supplemental oxygen
Fierce Biotech
Mon, 01/4/21 - 10:22 am
Redhill Biopharma
clinical trials
COVID-19
opaganib
AstraZeneca, still in asset-sale mode, hands off most global rights for constipation med Movantik
Fierce Pharma
Tue, 02/25/20 - 04:54 pm
AstraZeneca
Redhill Biopharma
constipation
Movantik
FDA Approves Talicia To Treat Superbug Linked To Stomach Cancer
Forbes
Sat, 11/16/19 - 10:34 pm
superbugs
antibiotics
antibiotic resistance
Talicia
FDA
stomach bug
Helicobecter pylori
Redhill Biopharma
As resistance to standard antibiotics grows, RedHill's H. pylori regimen secures FDA approval
Endpoints
Mon, 11/4/19 - 10:22 am
WHO
H pylori
Redhill Biopharma
antibiotics
antibiotic resistance
rifabutin
FDA
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Sun, 10/27/19 - 10:55 pm
Adamis Pharmaceuticals
Redhill Biopharma
Amag Pharmaceuticals
Arqule
Agile Therapeutics
Agios Pharmaceuticals
Deciphera
Mirati Therapeutics
Sutro BioPharma
Merck
Pfizer
Amgen
EXACT Sciences
Bristol-Myers Squibb
Celgene
Oyster Point Pharma
RedHill’s RHB-104 hits primary endpoint in Crohn’s phase 3
Fierce Biotech
Mon, 07/30/18 - 11:23 am
Redhill Biopharma
clinical trials
Crohn's Disease
RHB-104
5 Small-Cap Biotechs With Big Potential
TheStreet.com
Mon, 08/1/16 - 09:26 am
biotech
Portola Pharmaceuticals
Progenics
Redhill Biopharma
Dynavax
Amicus Therapeutics
Biotech Stocks Make Big Moves In Final Days Of 2014
Yahoo/Benzinga
Wed, 12/31/14 - 11:49 am
NeuroDerm
Arrowhead Research
Rockwell Medical
Redhill Biopharma
Cytokinetics
NephroGenex
FDA rejects RedHill's and IntelGenx's migraine drug
Yahoo/Reuters
Tue, 02/4/14 - 09:32 am
FDA
Redhill Biopharma
migraines
IntelGenx
RHB-103
Redhill Seeks Migraine, Oncology Partners After Nasdaq Listing
Bloomberg
Tue, 01/29/13 - 09:24 am
migraines
oncology
Redhill Biopharma